.png)
8 Jun 25, 2026
WHO-GMP Certified | High-Quality Antibiotic Supply for B2B Partners Worldwide
Scot Derma Private Limited stands as a trusted name in the pharmaceutical industry, specializing in the manufacturing and supply of high-quality Clindamycin Hydrochloride 300 mg Capsules. As a prominent B2B pharma partner, we deliver reliable, effective, and regulatory-compliant antibiotic solutions to distributors, exporters, PCD franchisees, hospitals, and institutional buyers across India and global markets.
Our state-of-the-art manufacturing facility in Panchkula, equipped with advanced technology and adhering to stringent WHO-GMP and ISO 9001:2015 standards, ensures every batch of Clindamycin Hydrochloride 300 mg Capsules meets international quality benchmarks. We focus on delivering consistent therapeutic efficacy while maintaining competitive pricing for bulk orders.
Clindamycin Hydrochloride is a potent lincosamide antibiotic widely used to treat serious bacterial infections caused by susceptible anaerobic bacteria, streptococci, pneumococci, and staphylococci. The 300 mg capsule strength is a standard dosage form preferred for moderate to severe infections in adults.
Clindamycin works by inhibiting bacterial protein synthesis, making it highly effective against a broad spectrum of gram-positive and anaerobic organisms. It is particularly valuable in cases where patients are allergic to penicillin or when other antibiotics prove ineffective.
At Scot Derma, quality is non-negotiable. Our dedicated production lines for oral solid dosage forms feature automated capsule filling machines, precision blending equipment, and rigorous in-process controls. Every capsule contains Clindamycin Hydrochloride equivalent to 300 mg of Clindamycin base, with uniform content and excellent dissolution profiles.
Our facility includes:
Scot Derma maintains comprehensive documentation including COA, CTD dossiers, stability data, and manufacturing licenses. We support regulatory filings for our B2B partners and ensure compliance with pharmacopeial standards (USP/IP/BP). Our quality management system undergoes regular audits, guaranteeing consistent product excellence.
We offer highly competitive bulk pricing structures tailored for PCD franchisees, exporters, and institutional buyers. Whether you need 1 lakh or 50 lakh capsules per month, our production capacity ensures timely delivery without compromising quality.
Enhance your market presence with custom-printed capsules, bespoke packaging, and your own brand name. Our experienced team assists with artwork design and regulatory compliance for private label manufacturing.
With robust cold-chain and temperature-controlled shipping capabilities, we export Clindamycin Hydrochloride 300 mg Capsules to multiple countries. We provide complete export documentation, including Certificate of Origin, GMP certificates, and Free Sale Certificates.
Our process begins with sourcing premium-grade Clindamycin Hydrochloride API from approved vendors. Raw materials undergo strict incoming quality checks. The blending, granulation (if required), encapsulation, polishing, and packaging stages are monitored by qualified personnel using validated SOPs.
Finished products are subjected to comprehensive testing:
While Clindamycin is a powerful antibiotic, responsible use is essential. We emphasize proper labeling with warnings regarding potential side effects such as gastrointestinal disturbances (including risk of C. difficile-associated diarrhea), allergic reactions, and the importance of completing the full course as prescribed.
The global demand for Clindamycin remains strong due to its efficacy against resistant strains and diverse clinical applications, especially in dermatology, dentistry, and surgical prophylaxis. As a specialized derma-focused company, Scot Derma is uniquely positioned to support partners in the skin and soft tissue infection segments where Clindamycin excels.
Join our growing network of satisfied B2B partners who trust Scot Derma for consistent quality, timely supply, and exceptional service. Whether you are looking for a reliable third-party manufacturer, PCD franchise opportunity, or export supplier, we are ready to build a long-term profitable relationship.
Contact Us: Scot Derma Private Limited, Panchkula, India
Phone: +91 99156 58300 | Email: sales@scotderma.com
Website: www.scotderma.com
For adults, serious infections are typically treated with 150-300 mg every 6 hours, while more severe infections may require 300-450 mg every 6 hours. Always follow physician prescription.
Yes. We provide full private labeling, custom blister designs, and bulk packaging options to suit your market requirements.
We operate under WHO-GMP and ISO 9001:2015 certifications, ensuring international quality standards.
MOQ varies by requirement but starts from reasonable commercial batches suitable for PCD franchisees and distributors. Contact us for exact details.
Through validated stability studies, premium excipients, and moisture-resistant packaging like Alu-Alu blisters.
Yes. We provide all necessary regulatory documents and have experience exporting to various regulated and semi-regulated markets.
Common side effects include nausea, vomiting, diarrhea, abdominal pain, and rash. Serious risks like pseudomembranous colitis should be highlighted.
Yes, we can support 150 mg and other strengths based on demand and regulatory approvals.
With years of expertise in dermatology and general pharma manufacturing, Scot Derma delivers more than just capsules — we deliver trust, quality, and business growth for our partners. Contact our dedicated B2B team today to discuss your Clindamycin Hydrochloride 300 mg Capsules requirements and secure your supply chain with a reliable manufacturer.
Scot Derma — Excellence in Every Capsule. Your Trusted Pharma Manufacturing Partner.
Welcome to Scot Derma Private Limited, a leading Skin Care pharma company in India. We are one of the top DERMA PCD Pharma Company in India with global locations and having our marketing office in India.
© 2019 SCOT DERMA PRIVATE LIMITED. All Rights Reserved.